Its efficiency is on par with the original and most widely used CRISPR-Cas system ... defense mechanism from the bacterial species Streptococcus pyogenes. But other bacterial species also have ...

Vienna, Austria – May 9th 2025 – Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its ...

CRISPR-Cas systems are prokaryotic immune systems ... a precise method for genetic modification in Streptococcus pneumoniae that enables high-throughput and scalable genome editing.

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in ... a precise method for genetic modification in Streptococcus pneumoniae that enables high-throughput and scalable ...